Literature DB >> 32329370

The Truth behind the Zeros: A New Approach to Principal Component Analysis of the Neuropsychiatric Inventory.

Kristoffer H Hellton1, Jeffrey Cummings2, Audun Osland Vik-Mo3,4, Jan Erik Nordrehaug5,6, Dag Aarsland3,7, Geir Selbaek8,9,10, Lasse Melvaer Giil5,11.   

Abstract

Psychiatric syndromes in dementia are often derived from the Neuropsychiatric Inventory (NPI) using principal component analysis (PCA). The validity of this statistical approach can be questioned, since the excessive proportion of zeros and skewness of NPI items may distort the estimated relations between the items. We propose a novel version of PCA, ZIBP-PCA, where a zero-inflated bivariate Poisson (ZIBP) distribution models the pairwise covariance between the NPI items. We compared the performance of the method to classical PCA under zero-inflation using simulations, and in two dementia-cohorts (N = 830, N = 1349). Simulations showed that component loadings from PCA were biased due to zero-inflation, while the loadings of ZIBP-PCA remained unaffected. ZIBP-PCA obtained a simpler component structure of "psychosis," "mood" and "agitation" in both dementia-cohorts, compared to PCA. The principal components from ZIBP-PCA had component loadings as follows: First, the component interpreted as "psychosis" was loaded by the items delusions and hallucinations. Second, the "mood" component was loaded by depression and anxiety. Finally, the "agitation" component was loaded by irritability and aggression. In conclusion, PCA is not equipped to handle zero-inflation. Using the NPI, PCA fails to identify components with a valid interpretation, while ZIBP-PCA estimates simple and interpretable components to characterize the psychopathology of dementia.

Entities:  

Keywords:  Monte Carlo simulation; Neuropsychiatric Inventory; bivariate Poisson distribution; principal component analysis; zero-inflation

Mesh:

Year:  2020        PMID: 32329370      PMCID: PMC8867488          DOI: 10.1080/00273171.2020.1736976

Source DB:  PubMed          Journal:  Multivariate Behav Res        ISSN: 0027-3171            Impact factor:   5.923


  37 in total

1.  Component Analysis versus Common Factor Analysis: Some issues in Selecting an Appropriate Procedure.

Authors:  W F Velicer; D N Jackson
Journal:  Multivariate Behav Res       Date:  1990-01-01       Impact factor: 5.923

2.  A Comparative Investigation of Rotation Criteria Within Exploratory Factor Analysis.

Authors:  Daniel A Sass; Thomas A Schmitt
Journal:  Multivariate Behav Res       Date:  2010-01-29       Impact factor: 5.923

3.  Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial.

Authors:  Geke A H van den Elsen; Amir I A Ahmed; Robbert-Jan Verkes; Cees Kramers; Ton Feuth; Paul B Rosenberg; Marjolein A van der Marck; Marcel G M Olde Rikkert
Journal:  Neurology       Date:  2015-05-13       Impact factor: 9.910

4.  The stability of neuropsychiatric subsyndromes in Alzheimer's disease.

Authors:  Michael H Connors; Katrin M Seeher; John Crawford; David Ames; Michael Woodward; Henry Brodaty
Journal:  Alzheimers Dement       Date:  2018-03-13       Impact factor: 21.566

Review 5.  Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of behavior and mood scales.

Authors:  A Perrault; M Oremus; L Demers; S Vida; C Wolfson
Journal:  J Geriatr Psychiatry Neurol       Date:  2000       Impact factor: 2.680

6.  Efficacy of memantine on neuropsychiatric symptoms associated with the severity of behavioral variant frontotemporal dementia: A six-month, open-label, self-controlled clinical trial.

Authors:  Pan Li; Wei Quan; Yu-Ying Zhou; Yan Wang; Hui-Hong Zhang; Shuai Liu
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

7.  Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.

Authors:  Martin Steinberg; Kyle Hess; Chris Corcoran; Michelle M Mielke; Maria Norton; John Breitner; Robert Green; Jeannie Leoutsakos; Kathleen Welsh-Bohmer; Constantine Lyketsos; Joann Tschanz
Journal:  Int J Geriatr Psychiatry       Date:  2013-05-17       Impact factor: 3.485

8.  Enduring increased risk of developing depression and mania in patients with dementia.

Authors:  F M Nilsson; L V Kessing; T M Sørensen; P K Andersen; T G Bolwig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-07       Impact factor: 10.154

Review 9.  Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms.

Authors:  Krista L Lanctôt; Joan Amatniek; Sonia Ancoli-Israel; Steven E Arnold; Clive Ballard; Jiska Cohen-Mansfield; Zahinoor Ismail; Constantine Lyketsos; David S Miller; Erik Musiek; Ricardo S Osorio; Paul B Rosenberg; Andrew Satlin; David Steffens; Pierre Tariot; Lisa J Bain; Maria C Carrillo; James A Hendrix; Heidi Jurgens; Brendon Boot
Journal:  Alzheimers Dement (N Y)       Date:  2017-08-05

Review 10.  The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders.

Authors:  Claudia K Y Lai
Journal:  Clin Interv Aging       Date:  2014-07-08       Impact factor: 4.458

View more
  3 in total

1.  Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.

Authors:  Willem S Eikelboom; Esther van den Berg; Ellen H Singleton; Sara J Baart; Michiel Coesmans; Annebet E Leeuwis; Charlotte E Teunissen; Bart N M van Berckel; Yolande A L Pijnenburg; Philip Scheltens; Wiesje M van der Flier; Rik Ossenkoppele; Janne M Papma
Journal:  Neurology       Date:  2021-08-19       Impact factor: 9.910

Review 2.  Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer's disease: A systematic review and meta-analysis.

Authors:  Shaun Kuan Wei Hiu; Theophile Bigirumurame; Patience Kunonga; Andrew Bryant; Manjunadh Pillai
Journal:  Brain Behav       Date:  2022-08-08       Impact factor: 3.405

3.  Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.

Authors:  Kok Pin Ng; Tharick A Pascoal; Sulantha Mathotaarachchi; Yiong Huak Chan; Lai Jiang; Joseph Therriault; Andrea L Benedet; Monica Shin; Nagaendran Kandiah; Celia M T Greenwood; Pedro Rosa-Neto; Serge Gauthier
Journal:  Transl Neurodegener       Date:  2021-01-04       Impact factor: 8.014

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.